SMYD3-driven CDCP1 expression in cancer cells indirectly reprograms neighboring fibroblasts toward a myofibroblastic, pro-tumor phenotype, bridging nuclear epigenetic control with stromal activation [42,43]. Here, SMYD3 is linked to cancer.